Literature DB >> 21475989

Zygomycosis presenting a major clinical challenge: case report on Rhizomucor pusillus infection in a stem-cell-transplant recipient.

Sanna-Maria Kivivuori1, Riitta Karikoski, Pirkko Koukila-Kähkölä, Veli-Jukka Anttila, Ulla M Saarinen-Pihkala.   

Abstract

Zygomycoses are opportunistic infections caused by the Mucorales fungi. They are typically seen in immunosuppressed patients. The incidence of zygomycosis cases seems to be increasing. We report on zygomycosis in a pediatric, female stem-cell-transplant recipient. This case report underlines the difficulty of taking care of patients with zygomycosis. In fungal infections of immunosuppressive patients on broad-coverage antibiotics, foci of skin necrosis are unique and typical for zygomycoses, and may be helpful in this challenging diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475989     DOI: 10.1007/s11046-011-9424-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  17 in total

1.  Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

Authors:  Francisco M Marty; Lisa A Cosimi; Lindsey R Baden
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

2.  Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia.

Authors:  Jan Sörensen; Martina Becker; Luciana Porto; Evelyn Lambrecht; Tobias Schuster; Florian Beske; Volker Rickerts; Thomas Klingebiel; Thomas Lehrnbecher
Journal:  Mycoses       Date:  2006       Impact factor: 4.377

3.  Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Authors:  Susanne Perkhofer; Maria Locher; Manuel Cuenca-Estrella; Reinhard Rüchel; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

4.  Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.

Authors:  Mayssa M Abuali; Roberto Posada; Gustavo Del Toro; Elizabeth Roman; Rama Ramani; Sudha Chaturvedi; Vishnu Chaturvedi; Vincent J LaBombardi
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 5.  Outbreaks of zygomycosis in hospitals.

Authors:  A Antoniadou
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

Review 6.  Invasive zygomycosis in neonates and children.

Authors:  E Roilides; T E Zaoutis; T J Walsh
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

7.  Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

Review 8.  Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients.

Authors:  Kimberly Partridge-Hinckley; Gale M Liddell; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2009-12       Impact factor: 2.574

Review 9.  Zygomycosis in children: a systematic review and analysis of reported cases.

Authors:  Theoklis E Zaoutis; Emmanuel Roilides; Christine C Chiou; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Priya A Prasad; Jaclyn H Chu; Thomas J Walsh
Journal:  Pediatr Infect Dis J       Date:  2007-08       Impact factor: 2.129

10.  Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.

Authors:  Dounia Bitar; Dieter Van Cauteren; Fanny Lanternier; Eric Dannaoui; Didier Che; Francoise Dromer; Jean Claude Desenclos; Olivier Lortholary
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more
  5 in total

1.  Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology.

Authors:  Sagarika Banerjee; Kristen N Peck; Michael D Feldman; Mindy G Schuster; James C Alwine; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

2.  Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen.

Authors:  Eduardo Flavio Oliveira Ribeiro; Vitorino Modesto dos Santos; Guilherme Teixeira Guimarães Paixão; Leonardo Rodrigues Cruz; Milena Zamian Danilow; Vinicius Ferreira Campos
Journal:  Mycopathologia       Date:  2013-02-27       Impact factor: 2.574

3.  Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature.

Authors:  Sarah Schober; Karin Melanie Cabanillas Stanchi; Anna Riecker; Matthias Pfeiffer; Ilias Tsiflikas; Gesa Wiegand; Leticia Quintanilla-Martinez; Susanne Haen; Martin Ebinger; Peter Lang; Rupert Handgretinger; Michaela Döring
Journal:  Med Mycol Case Rep       Date:  2020-12-29

4.  Rhizomucor pusillus Infection in a Patient with Acute Myeloid Leukaemia After Haematopoietic Stem Cell Transplantation: Clinical Impact of Metagenomics Next-Generation Sequencing.

Authors:  Lilin Liu; Huiqin Wu; Jianghong Liang; Wenhao Wu; Ye Peng; Hua Zhou; Xi Li
Journal:  Infect Drug Resist       Date:  2022-08-06       Impact factor: 4.177

5.  First case report of bloodstream infection by Rhizomucor pusillus in a child with hemophagocytic lymphohistiocytosis.

Authors:  Jennifer Dien Bard; Aida Mangahis; Thomas C Hofstra; Jeffrey M Bender
Journal:  Med Mycol Case Rep       Date:  2014-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.